1.
Temozolomide in aggressive pituitary adenomas and carcinomas. Clinics [Internet]. 2012 Jan. 1 [cited 2024 May 7];67(supl.1):119-23. Available from: https://www.revistas.usp.br/clinics/article/view/19731